September 30, 2024
test
September 5, 2019
Expenditures on drugs in public plans have increased by an average of 6.6% annually since 2014-15
August 14, 2019
Latest agreement between public payers and the Canadian generic industry closes gap with international prices
August 9, 2019
Patented Medicine Prices Review Board (PMPRB) Chairperson Dr. Mitchell Levine made the following statement regarding Health Canada’s final amendments to the Patented Medicines Regulations.
May 30, 2019
The Patented Medicine Prices Review Board (PMPRB), through the National Prescription Drug Utilization Information System (NPDUIS) research initiative, today published the 2018 edition of Meds Pipeline Monitor.